Lixisenatide
Generic Name: lixisenatide
Manufactured by SANOFI-AVENTIS US. Dosage form: SOLUTION. Route: SUBCUTANEOUS. Active ingredients: LIXISENATIDE (0.3MG/3ML (0.1MG/ML)). Application: BLA208471.
Overview
Manufactured by SANOFI-AVENTIS US. Dosage form: SOLUTION. Route: SUBCUTANEOUS. Active ingredients: LIXISENATIDE (0.3MG/3ML (0.1MG/ML)). Application: BLA208471.
Dosage
Available as solution for subcutaneous use.
Related Medications
Methenamine Mandelate
methenamine mandelate
DESCRIPTION: Methenamine mandelate, USP, a urinary antibacterial agent, is the chemical combination of mandelic acid with methenamine. Methenamine mandelate, USP is available for oral use as film-coated tablets. Active Ingredients: Methenamine Mandelate: 500 mg or 0.5 gm. Methenamine Mandelate: 1000 mg or 1.0 gm.
Metformin Hydrochloride || Sitagliptin
metformin hydrochloride || sitagliptin
Manufactured by MACLEODS PHARMS LTD. Dosage form: TABLET:FILM COATED. Route: FILM COATED. Active ingredients: METFORMIN HYDROCHLORIDE || SITAGLIPTIN (50MG). Application: ANDA212338.
Calendula, Graphites, Hypericum Perforatum, Staphysagria, Silicea, Thiosinaminum
calendula, graphites, hypericum perforatum, staphysagria, silicea, thiosinaminum
USES: Aids in the reduction of scar tissue.**
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.